As of 2025-05-15, the Relative Valuation of Celldex Therapeutics Inc (CLDX) is (61.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.94 USD, the upside of Celldex Therapeutics Inc based on Relative Valuation is -425.8%.
The range of the Relative Valuation is (53.70) - (77.10) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.8x - 34.4x | 23.8x |
| Forward P/E multiples | 22.6x - 32.4x | 28.1x |
| Fair Price | (53.70) - (77.10) | (61.71) |
| Upside | -383.5% - -507.1% | -425.8% |
| Date | P/E |
| 2025-05-12 | -8.49 |
| 2025-05-09 | -7.71 |
| 2025-05-08 | -8.21 |
| 2025-05-07 | -7.95 |
| 2025-05-06 | -7.74 |
| 2025-05-05 | -8.53 |
| 2025-05-02 | -8.69 |
| 2025-05-01 | -8.71 |
| 2025-04-30 | -8.76 |
| 2025-04-29 | -8.80 |
| 2025-04-28 | -8.98 |
| 2025-04-25 | -8.23 |
| 2025-04-24 | -8.23 |
| 2025-04-23 | -8.17 |
| 2025-04-22 | -8.15 |
| 2025-04-21 | -7.96 |
| 2025-04-17 | -7.69 |
| 2025-04-16 | -7.48 |
| 2025-04-15 | -7.72 |
| 2025-04-14 | -7.48 |
| 2025-04-11 | -7.08 |
| 2025-04-10 | -6.70 |
| 2025-04-09 | -6.90 |
| 2025-04-08 | -6.36 |
| 2025-04-07 | -6.61 |
| 2025-04-04 | -6.64 |
| 2025-04-03 | -7.21 |
| 2025-04-02 | -7.31 |
| 2025-04-01 | -7.09 |
| 2025-03-31 | -7.63 |
| 2025-03-28 | -8.38 |
| 2025-03-27 | -8.40 |
| 2025-03-26 | -8.23 |
| 2025-03-25 | -8.47 |
| 2025-03-24 | -8.74 |
| 2025-03-21 | -8.26 |
| 2025-03-20 | -8.36 |
| 2025-03-19 | -8.39 |
| 2025-03-18 | -8.36 |
| 2025-03-17 | -8.56 |
| 2025-03-14 | -8.59 |
| 2025-03-13 | -8.47 |
| 2025-03-12 | -8.90 |
| 2025-03-11 | -8.62 |
| 2025-03-10 | -8.22 |
| 2025-03-07 | -8.69 |
| 2025-03-06 | -8.97 |
| 2025-03-05 | -8.87 |
| 2025-03-04 | -8.41 |
| 2025-03-03 | -8.14 |